Inventor · disambiguated record
Richard S. Pottorf
Also filed as: POTTORF RICHARD S · POTTORF RICHARD SCOTT
12 granted patents·7 pending applications·246 citations·filing 1991–2024
91Inventor score
Top patents by PatentIndex Score
19 records- 0194US9376437B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2014·Granted Jun 28, 2016·11 cites·9 claims
- 0292US5260325AAngiotensin II receptor blocking tertiary amidesDU PONT·Filed 1991·Granted Nov 9, 1993·61 cites·6 claims
- 0391US2025109133A17-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[l,2-A]PYRIDO[3,4-E] PYRIMIDIN-5 (1 H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FORTHEIR USE IN THERAPYCHIMERIX INC·Filed 2024·Application pending·0 cites
- 0489US8894970B2Arginase inhibitors and methods of use thereofTOMCZUK BRUCE EDWARD·Filed 2011·Granted Nov 25, 2014·25 cites·2 claims
- 0588US2024270746A17-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidaz0[1,2-a]pyrid0[3,4-e] pyrimidin-5 (1 h)-one, analogs thereof, and salts thereof and methods for their use in therapyCHIMERIX INC·Filed 2024·Application pending·0 cites
- 0687US9265765B27-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2014·Granted Feb 23, 2016·10 cites·3 claims
- 0786US5786331APeptides and compounds that bind to the IL-1 receptorAFFYMAX TECH NV·Filed 1995·Granted Jul 28, 1998·94 cites·1 claims
- 0879US11976068B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyCHIMERIX INC·Filed 2021·Granted May 7, 2024·0 cites·2 claims
- 0979US5861476APeptides and compounds that bind to the IL-1 receptorAFFYMAX TECH NV·Filed 1995·Granted Jan 19, 1999·39 cites·4 claims
- 1077US10266533B27-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyONCOCEUTICS INC·Filed 2017·Granted Apr 23, 2019·1 cites·15 claims
- 1175US8952150B2Prostaglandin transporter inhibitors and uses thereofSCHUSTER VICTOR L·Filed 2010·Granted Feb 10, 2015·4 cites·31 claims
- 1274US9845324B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyONCOCEUTICS INC·Filed 2016·Granted Dec 19, 2017·1 cites·26 claims
- 1366US2019194201A17-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, analogs thereof, and salts thereof and methods for their use in therapyONCOCEUTICS INC·Filed 2019·Application pending·0 cites
- 1460US2020223871A1Arginase Inhibitors and Methods of UseASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 1557US2019127395A1Arginase Inhibitors and Methods of UseASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 1653US10118936B2Arginase inhibitors and methods of useASTRAZENECA AB·Filed 2015·Granted Nov 6, 2018·0 cites·22 claims
- 1748US2010189644A1Arginase inhibitors and methods of useUNIV PENNSYLVANIA·Filed 2010·Application pending·0 cites
- 1842US9447122B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2015·Granted Sep 20, 2016·0 cites·14 claims
- 1935US2006014812A1Use of estrogen related receptor-modulating aryl ethersPLAYER MARK R·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →